To ensure access to quality and affordable care for cancer patients within their communities.

 

Links:

Membership
Clinical Pathways

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Email Newsletter
 
Upcoming Events

Save-the-date! Friday, September 19, 2014!
MOASC NURSE PROGRAM IN PASADENA.
You do not want to miss this informative and engaging half-day program!

7:30am      Registration – Breakfast – Exhibit Hall
8:00am      Welcome & Introductions
8:15am      Oral Adherence presented by:
                    Flora Woo, MSN, RN, Senior Clinical Nurse Consultant, Celgene Corporation
9:15am      Break/Refreshments – Exhibit Hall – Raffle
9:35am      Compassion Fatigue: Building Resilience in Oncology Nurses presented by:
                    Katherine Joyce Janzen RN, MN, ONC(C)
                    Assistant Professor, School of Nursing                    and Midwifery
                    Faculty of Health and Community Studies
                    Mount Royal University, Calgary, Alberta, Canada.
11:00am    The Art of Active Listening (AAL) presented by:
                    Ms. Selinza Ann Mitchell, CNS, Oncology                     Clinical Nurse Educator, Pfizer Oncology

For more information and to register, email moasc@moasc.org or call 909-985-9061 ext. 1.

This meeting is being sponsored in part by the following companies:

Celgene, Pfizer, OncoQol, American Regent, Eisai, Merck, McKesson

Save-the-date! Wednesday, October 22, 2014!
The MOASC Administrator Meeting will be held at the Disneyland Hotel in Anaheim.
The speakers and topics will be announced shortly.
For more information and to register, email moasc@moasc.org or call 909-985-9061 ext. 1.

Save-the-date!  Friday, November 14, 2014!
The MOASC Oncology Summit will be held at the InterContinental Hotel in Century City.
The schedule is:
5:00pm      Networking Reception - Exhibit Hall
6:30pm      Dinner – Welcome & Introductions
7:00pm      Keynote presentation
                    Physician Hospital Partnerships: What                    they look like, Whether they work
                    and Should you consider one?

Presented by:
                    Lawrence D. Piro, M.D.
                    President & CEO, The Angeles Clinic
                    MOASC Board of Directors
                    Chair, MOASC Executive Committee
8:30pm      Program concludes

For more information and to register, email moasc@moasc.org or call 909-985-9061 ext. 1.
This meeting precedes Research To Practice - Year In Review Program with Dr. Neil Love on
Saturday, November 15, 2014. For more information visit: www.researchtopractice.com

 
 
  <
Hot Topics

Nurse Practitioner's, Physician Assistant's, Oncology Nurses and Pharmacists should not miss any opportunity for professional and personal development, not to mention visiting with fellow professionals, at MOASC's Clinical Support program, Friday, September 19th in Pasadena. Contact moasc@moasc.org for more information.

CMA's Practice Resources September 2015 www.cmanet.org/cpr is now available online and features articles entitled: No on Prop 46--get engaged; United to make some changes to Premium Designation program, but concerns remain; Change in prior authorization form for prescription medicines becomes effective October 1; Noridian denies 300,000 claims for E&M services in error; System error causing some Anthem Blue Cross claims to be underpaid; The Coding Corner: Time as the controlling factor in E&M coding. For more information, click here.

Noridian/JEMAC's website www.med.noridianmedicare.com/web/jeb has posted the following updates: ICD-10 Testing--Acknowledgement Testing with Providers; September Web-based Workshops; Endeavor Now Offers Claim Comments as Part of Claim Status Results;  For more information, click here.

Last week, the Federation of State Medical Boards released model legislation to create an interstate compact for physician licensure that aims to facilitate the licensing of doctors across state borders. Though the move is seen as facilitating the growth of telemedicine and speeding increased healthcare access to residents in rural areas, and the American Medical Association applauds the compact, the Health IT Now Coalition says FSMB could do more to enhance telehealth services. For more information, click here.

Tomorrow, Wednesday, September 10 is the last day that physicians can review, and if necessary dispute their financial interactions as reported under the Physician Payments Sunshine Act. The Sunshine Act is a provision of the Patient Protection and Affordable Care Act that requires drug and medical device manufacturers and group purchasing organizations (GPOs) to report their financial interactions with licensed physicians - including consulting fees, travel reimbursements, research grants and other gifts. Any payments, ownership interests and other "transfers of value" will be reported to CMS for publication in an online database. This data will be made public via the Open Payments website beginning on September 30. Physicians should be aware that there is a two-step registration process for the Open Payments program. The first step requires physicians to register at the CMS Enterprise Portal, a step many physicians may have already completed as the gateway enables access to a number of other CMS programs. Step two is to register in CMS' Open Payments system. Physicians and authorized representatives can submit questions to the CMS Help Desk at openpayments@cms.hhs.gov. Live Help Desk support is also available by calling (855) 326-8366, Monday through Friday, from 5:30 a.m. to 4:30 p.m. Pacific time, excluding Federal holidays. For more information, click here.

 
 
MOASC Information

Wednesday, September 10, 2014, 12:00pm - 1:00pm PST. 
Due to overwhelming interest and realization of needing to be prepared, MOASC is
providing an encore presentation of, "Medicare Physician Fee Schedule (PFS)
2015 Proposed Rule, the Value Based Modifier and Changes to Physician
Quality Programs." 
Presented byKelly Davies, Healthcare Policy & Advocacy
Director, Southern CA, Strategic Customer Group, Johnson & Johnson Health
Care Systems Inc. For more information on the 2015 proposed rule, click here.
Physicians may lose up to 9% in Medicare revenue come 2017! 
You cannot afford to miss this encore presentation on Wednesday,
September 10, 2014, 12:00pm - 1:00pm PST. 
To RSVP contact Danielle Overman at moasc@moasc.org.

The MOASC LunchTime Series Webinar was held on August 27th.
The first presentation was "Medicare Physician Fee Schedule (PFS) 2015 Proposed Rule, the Value Based Modifier and Changes to
Physician Quality Programs”
Presented by:Kelly Davies, Healthcare Policy & Advocacy Director, Southern CA, Strategic Customer Group,
Johnson & Johnson Health Care Systems Inc. The second presentation was "Eliminating Collection Costs While Reducing Accounts
Receivables by More Than 61%" 
Presented by:Shawn Ecksel, Vice President, Sales and Development, USPAY.  For a copy of the
handouts, please send an email to moasc@moasc.org

If you did not attend last Wednesday's LunchTime Series Teleconference, "California Regulated Medical Waste Management and Proper Waste Segregation," presented by Richard Best, Technical Director, Stericycle, Inc., you can listen to the recording by dialing 1-888-203-1112 and enter the pass code 353441415#This recording will be available for the next 30 days. To view the handouts for the presentation, please email Danielle Overman at moasc@moasc.org.

Rosetta Genomics announced that enrollment has begun for a prospective Registry of U.S. patients whose tumor biopsy samples have been analyzed by a microRNA-based Gene Expression Profiling (GEP) assay.  This study has been initiated because emerging clinical evidence appears to support the clinical value of this type of testing to improve diagnostic certainty of a specific cancer diagnosis. It is intended that this Registry Study will add considerable evidence validating the clinical utility of microRNA-based GEP by evaluating its impact on patient treatment. Your participation in this Registry Study is therefore vital to its success.  Compensation for completing the Actionability survey for each patient, enrolling each patient and for entering follow-up data will be provided.  For more details please visit http://www.rosettagenomics.com/files/dmfile/registry_
announcement_letter.pdf
or contact Janet Bernard, Study Coordinator: Tel 617-532-5709 or emailjbernard@medpanel.com and / or email to E. Robert Wassman, MD: Robert_wa@rosettagenomics.com.

 

Thank you to the following sponsors for assisting MOASC in achieving their mission.

Platinum:
Diamond:
Bayer Healthcare Pharmaceuticals, Cardinal Health Specialty Solutions, Lilly Oncology, Oncology Supply, Teva Oncology
Gold:

Amgen, Astellas Oncology, Novartis
Silver:
AMAG Pharmaceuticals, AstraZeneca, Dendreon, Genentech, Genomic Health, McKesson Specialty Health, Merck Oncology, Millennium, Onyx Pharmaceuticals, Pfizer, Pharmacyclics, Rosetta Genetics, Seattle Genetics, Sanofi Oncology
Other:

BMS, Myriad

 
© 2008 - 2014 Medical Oncology Association of Southern California
P.O. Box 161   •    Upland, CA 91785
Phone: (909) 985-9061   •    Fax: (909) 985-8581   •   email:
moasc@moasc.org

Open Central 

inland empire website design wow webs